Bristol-Myers Squibb (United Kingdom)

558 papers and 8.6k indexed citations i.

About

In recent decades, authors affiliated with Bristol-Myers Squibb (United Kingdom) have published 558 papers, which have received a total of 8.6k indexed citations. Scholars at this organization have produced 150 papers in Oncology, 124 papers in Economics and Econometrics and 96 papers in Pulmonary and Respiratory Medicine on the topics of Health Systems, Economic Evaluations, Quality of Life (100 papers), Cancer Immunotherapy and Biomarkers (77 papers) and Economic and Financial Impacts of Cancer (66 papers). Their work is cited by papers focused on Molecular Biology (1.5k citations), Oncology (1.5k citations) and Pharmaceutical Science (1.4k citations). Authors at Bristol-Myers Squibb (United Kingdom) collaborate with scholars in United Kingdom, United States and France and have published in prestigious journals including Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology. Some of Bristol-Myers Squibb (United Kingdom)'s most productive authors include Peter Timmins, Mike Tobyn, Graham S. Clarke, Michael Leane, Colin D. Melia, Kendal Pitt, Gavin Reynolds, Matthew Doogue, Jerry R. Greenfield and Janna K. Duong.

In The Last Decade

Fields of papers published by authors at Bristol-Myers Squibb (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Bristol-Myers Squibb (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Bristol-Myers Squibb (United Kingdom) at the time of their publication.

Countries citing scholars working at Bristol-Myers Squibb (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Bristol-Myers Squibb (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Bristol-Myers Squibb (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bristol-Myers Squibb (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025